Showing results (1021-1030 of 6,495) with videos related to
Sort By:
Pageof 650
Journal of Thrombosis and Haemostasis : JTH|January 20, 2012
Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam StudyM C Van Schie, R G Wieberdink, P J Koudstaal, et al.Journal of Thrombosis and Haemostasis : JTH|March 16, 2012
Pulmonary embolism in sickle cell disease: a case-control studyE M Novelli, C Huynh, M T Gladwin, et al.Journal of Thrombosis and Haemostasis : JTH|November 2, 2011
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulenceT Vanassche, J Verhaegen, W E Peetermans, et al.Journal of Thrombosis and Haemostasis : JTH|January 4, 2012
In vivo monitoring of venous thrombosis in miceM N Aghourian, C A Lemarié, M D BlosteinJournal of Thrombosis and Haemostasis : JTH|March 14, 2012
Plasma factor VII-activating protease antigen levels and activity are increased in ischemic strokeE Hanson, S M Kanse, A Joshi, et al.Journal of Thrombosis and Haemostasis : JTH|March 14, 2012
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancerM N Levine, C Gu, H A Liebman, et al.Journal of Thrombosis and Haemostasis : JTH|March 14, 2012
A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopeniaY Tomiyama, Y Miyakawa, S Okamoto, et al.Journal of Thrombosis and Haemostasis : JTH|March 1, 2012
The genomic and proteomic blueprint of mouse megakaryocytes derived from embryonic stem cellsV Merico, M Zuccotti, D Carpi, et al.Journal of Thrombosis and Haemostasis : JTH|December 20, 2014
Real-world variability in dabigatran levels in patients with atrial fibrillationN C Chan, M Coppens, J Hirsh, et al.Journal of Thrombosis and Haemostasis : JTH|December 20, 2014
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activityL Zafrani, E Mariotte, M Darmon, et al.Pageof 650